Imaging Agents - Global Strategic Business Report

The global market for Imaging Agents is estimated at US$9.8 Billion in 2023 and is projected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Nuclear imaging and wearable technology are also driving advancements in medical imaging. Nuclear imaging uses radiotracers to provide detailed insights into internal conditions such as cancer and Alzheimer`s disease, with devices like the EXPLORER Total-body PET/CT Scanner improving efficiency. Wearables offer new applications in radiology, with the HD-DOT instrument and wearable ultrasound scanners enabling continuous brain and organ monitoring. These innovations are expanding diagnostic capabilities and improving patient care by providing earlier detection and more effective treatments.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Diagnostic Radiopharmaceuticals segment, which is expected to reach US$7.2 Billion by 2030 with a CAGR of a 5.9%. The X-Ray / CT segment is also set to grow at 3.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $2.7 Billion in 2023, and China, forecasted to grow at an impressive 7.9% CAGR to reach $2.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Imaging Agents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Imaging Agents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Imaging Agents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Aytu BioScience Inc., Bayer Healthcare Pharmaceuticals, Bracco Diagnostics Inc., and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 23 Featured):

• Aytu BioScience Inc.
• Bayer Healthcare Pharmaceuticals
• Bracco Diagnostics Inc.
• Curium
• Daiichi Sankyo Company Limited
• Eli Lilly
• GE Healthcare
• Guerbet Group
• Lantheus Medical Imaging Inc.
• Piramal Imaging SA